HTB | HIV i-Base

HTB

Remembered friends, VRC01 AMP studies, COVID variants, vaccines and treatments... plus more

Featured HTB: no. 2 – plus HIV and COVID-19 (24 February 2021) 24 February 2021. Related: Editorial.
Featured HTB: no. 1 – plus HIV and COVID-19 (22 January 2021) 22 January 2021. Related: Editorial.
Featured HTB: no. 13/14 – HIV and COVID-19: issue 10 (9 December 2020) 9 December 2020. Related: Editorial.
Featured HTB: no. 12 – HIV and COVID-19: issue 9 (11 November 2020) 11 November 2020. Related: Editorial.
Featured In Memory: Timothy Ray Brown, the Berlin patient, the first person to be cured of HIV 14 October 2020. Related: In Memory.
Ivermectin has no impact in treating mild COVID-19 in 400 adults in Columbia 6 March 2021. Related: Early access, COVID-19: investigational drugs, COVID-19.
No benefit from BRII and GSK monoclonal antibodies against COVID-19 in ACTIV-3 study 5 March 2021. Related: Early access, COVID-19: investigational drugs, COVID-19.
Chronic kidney disease (CKD) in HIV positive people linked to time with low CD4 count: partly reversible after effective ART 1 March 2021. Related: Early access, Side effects, OIs, coinfections and complications.
i-Base appeal: please support i-Base with £5 or £10 a month 24 February 2021. Related: Editorial.
In memory: Elias Phiri, community HIV and TB advocate 24 February 2021. Related: In Memory.
In memory: Dr Joseph Sonnabend, pioneer HIV activist and researcher 24 February 2021. Related: In Memory.
Timothy Ray Brown: a virtual memorial 24 February 2021. Related: In Memory.
R4P virtual conference (2021) 24 February 2021. Related: Conference reports, HIV prevention and transmission, Conference index, R4P 2021 Virtual.
VRC01 antibody only prevents minority of HIV infections: AMP study results 24 February 2021. Related: Conference reports, HIV prevention and transmission, R4P 2021 Virtual.
Long-acting bNAb is safe and well tolerated and achieves target concentrations in newborns (VRC07-523LS) 24 February 2021. Related: Conference reports, Paediatric care, HIV prevention and transmission, R4P 2021 Virtual.
Promising data for multipurpose technologies to prevent HIV and pregnancy 24 February 2021. Related: Conference reports, Pregnancy, HIV prevention and transmission, R4P 2021 Virtual.
12th International Workshop on HIV paediatrics 24 February 2021. Related: Conference reports, Conference index, 12th Paediatric HIV 2020.
New LPV/r-based fixed dose HIV combination for young children: first results with Quadrimune 4-in-1 24 February 2021. Related: Conference reports, Paediatric care.
UK study for people with triple-class drug resistance 24 February 2021. Related: Resistance, Research studies.
Community murals in Soweto on dolutegravir-based ART: an i-Base collaboration 24 February 2021. Related: Treatment advocacy.
HIV positive people in the UK now elligible for COVID vaccinations – and to become available at HIV clinics 24 February 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19: treatment access, COVID-19.
Main COVID-19 variants and their likely impact on vaccines 24 February 2021. Related: COVID-19: vaccine research, COVID-19: transmission & prevention, COVID-19.
Novavax: >90% efficacy in UK but 60% in South Africa, hints of lower effect in HIV positive participants 24 February 2021. Related: COVID-19: vaccine research, COVID-19.
Russian Sputnik vaccine reports 91% efficacy at 21 days after the first dose 24 February 2021. Related: COVID-19: vaccine research, COVID-19.
Janssen vaccine reports efficacy after single injection: FDA decision imminent 24 February 2021. Related: COVID-19: vaccine research, COVID-19.
Oxford/AZ vaccine might still prevent severe COVID-19 from B.1.351 variant: supports continued used in South Africa 24 February 2021. Related: COVID-19: vaccine research, COVID-19.
Unprecedented rapid speed of COVID vaccine development 24 February 2021. Related: COVID-19: vaccine research, COVID-19.
WHO online vaccine tracker 24 February 2021. Related: COVID-19: vaccine research, COVID-19.
COVID-19 vaccine pricing: a BBC guide 24 February 2021. Related: COVID-19: vaccine research, COVID-19: treatment access, COVID-19.
High rates of undocumented COVID-19 mortality in Zambia without testing challenges the idea that Africa has been spared 24 February 2021. Related: COVID-19: treatment access, COVID-19: pathogenesis.
Tocilizimab effectively reduces COVID-19 related deaths and hospitalisation time: additive benefit with dexamethasone 24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
Bamlanivimab (LY-CoV555) prophylaxis prevents COVID-19 in care homes: results of BLAZE-2 study 24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
US FDA specifies high antibody titre for convalescent plasma and to only use in early COVID-19 24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
No benefit from convalescent plasma in UK RECOVERY study: limited results restrict implications for COVID-19 24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
UK variant B.1.1.7 linked to higher risk of death and hospitalisation from COVID-19 24 February 2021. Related: COVID-19: pathogenesis, COVID-19.
Future meetings and webinars 2021 24 February 2021. Related: Future meetings.
HTB no 2 – plus HIV and COVID-19 (24 February 2021) 24 February 2021. Related: PDFs.
BHIVA 2020 virtual conference now online 22 January 2021. Related: Conference reports, Conference index, BHIVA 2020 virtual.
Single undetectable viral load is sufficient for U=U in the context of good adherence 22 January 2021. Related: Conference reports, HIV prevention and transmission, BHIVA 2020 virtual.
Selected plenary talks and workshops from BHIVA 2020 22 January 2021. Related: Conference reports, Other news, On the web.
US FDA approves long-acting injectable HIV treatment: monthly dosing 22 January 2021. Related: Antiretrovirals.
Long-acting injectable HIV treatment approved in the EU: includes two-monthly dosing 22 January 2021. Related: Antiretrovirals.
Fostemsavir approved in the EU (Rukobia): NICE deferred in the UK 22 January 2021. Related: Antiretrovirals.
PHE report on HIV and STIs during COVID-19 22 January 2021. Related: HIV prevention and transmission.
Baseline NNRTI resistance linked to poorer response to first-line dolutegravir in the ADVANCE study 22 January 2021. Related: Treatment strategies, Resistance.
Significant increases in LGV in gay men from 2017 to 2019: latest PHE report 22 January 2021. Related: OIs, coinfections and complications, Other news.
HIV criminalisation during 2020: cases continue but also legal advances 22 January 2021. Related: Other news.
NICE issue UK guidelines on long COVID 22 January 2021. Related: COVID-19: guidelines, COVID-19.
BHIVA and EACS update HIV as a higher risk for COVID-19: supports priority vaccine (January 2021) 22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Recent studies on HIV and COVID-19 coinfection 22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Very low-level HIV viraemia might continue after COVID-19 22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: pathogenesis, COVID-19.
Pfizer COVID-19 vaccine might still overcome UK and SA variants 22 January 2021. Related: COVID-19: vaccine research, COVID-19.
Novavax phase 3 vaccine study launched in the UK, South Africa, US, Mexico and Puerto Rico 22 January 2021. Related: COVID-19: vaccine research, COVID-19.